CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy‐dependent ferroptosis
Journal of Cellular Physiology · 2023-10 · 238 (10) · 2407-2424
DOI: 10.1002/jcp.31093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 11.08.2023. Verfasst von Ziqi Shang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, Stomach Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Major Scientific and Technological Innovation Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Cisplatin is the first‐line chemotherapy for gastric cancer (GC). However, its efficacy is dampened by the development of chemoresistance, which leads to poor prognosis in GC patients. Recently, evidence has revealed that circular RNAs (circRNAs) and dysregulation of autophagy‐dependent ferroptosis play critical roles in cancer chemoresistance. Herein, for the first time we report that circHIPK3 has a vital role in GC cisplatin resistance. CircHIPK3 regulated cisplatin resistance by targeting autophagy and ferroptosis. In brief, knockdown circHIPK3 decreased GC cell cisplatin resistance by enhancing ferroptosis via the miR‐508‐3p/Bcl‐2/beclin1/SLC7A11 axis. Taken together, our results demonstrate that ferroptosis is a promising strategy to ameliorate cisplatin resistance. Importantly, serum exosomal circHIPK3 could also be a noninvasive indicator to evaluate cisplatin resistance in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
- Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, China.
ORCID-Profile: Ziqi Shang, Yi Zhang
Förderung
- Major Scientific and Technological Innovation Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Shang, Z., Luo, Z., Wang, Y., Liu, Q., Xin, Y., Zhang, M., Li, X., Zeng, S., Yu, L., Zhang, X., & Zhang, Y. (2023). CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy‐dependent ferroptosis. Journal of Cellular Physiology, 238(10), 2407-2424. https://doi.org/10.1002/jcp.31093
Vancouver
Shang Z, Luo Z, Wang Y, Liu Q, Xin Y, Zhang M, et al. CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy‐dependent ferroptosis. Journal of Cellular Physiology. 2023;238(10):2407-2424. doi:10.1002/jcp.31093
BibTeX
@article{Shang2023,
author = {Shang, Ziqi and Luo, Zhengdong and Wang, Yifeng and Liu, Qi and Xin, Yiwei and Zhang, Mengjiao and Li, Xinyang and Zeng, Shunjie and Yu, Longchen and Zhang, Xin and Zhang, Yi},
title = {CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy‐dependent ferroptosis},
journal = {Journal of Cellular Physiology},
year = {2023},
volume = {238},
number = {10},
pages = {2407--2424},
doi = {10.1002/jcp.31093}
}
EUVIMED